HLN
Price
$9.51
Change
-$0.16 (-1.65%)
Updated
Dec 3 closing price
Capitalization
43.42B
83 days until earnings call
Intraday BUY SELL Signals
HLNCF
Price
$4.89
Change
-$0.02 (-0.41%)
Updated
Dec 2 closing price
Capitalization
43.73B
Intraday BUY SELL Signals
Interact to see
Advertisement

HLN vs HLNCF

Header iconHLN vs HLNCF Comparison
Open Charts HLN vs HLNCFBanner chart's image
Haleon
Price$9.51
Change-$0.16 (-1.65%)
Volume$12.25M
Capitalization43.42B
HALEON
Price$4.89
Change-$0.02 (-0.41%)
Volume$749
Capitalization43.73B
HLN vs HLNCF Comparison Chart in %
HLN
Daily Signal:
Gain/Loss:
HLNCF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HLN vs. HLNCF commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a StrongBuy and HLNCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (HLN: $9.66 vs. HLNCF: $4.91)
Brand notoriety: HLN and HLNCF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLN: 28% vs. HLNCF: 19%
Market capitalization -- HLN: $43.42B vs. HLNCF: $43.73B
HLN [@Pharmaceuticals: Generic] is valued at $43.42B. HLNCF’s [@Pharmaceuticals: Generic] market capitalization is $43.73B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 1 FA rating(s) are green whileHLNCF’s FA Score has 1 green FA rating(s).

  • HLN’s FA Score: 1 green, 4 red.
  • HLNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, both HLN and HLNCF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 4 TA indicator(s) are bullish while HLNCF’s TA Score has 6 bullish TA indicator(s).

  • HLN’s TA Score: 4 bullish, 5 bearish.
  • HLNCF’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, HLNCF is a better buy in the short-term than HLN.

Price Growth

HLN (@Pharmaceuticals: Generic) experienced а -1.58% price change this week, while HLNCF (@Pharmaceuticals: Generic) price change was +0.20% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.67%. For the same industry, the average monthly price growth was +0.42%, and the average quarterly price growth was +25.91%.

Reported Earning Dates

HLN is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.67% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLNCF($43.7B) and HLN($43.4B) have the same market capitalization . HLNCF (22.23) and HLN (21.54) have similar P/E ratio . HLNCF YTD gains are higher at: 5.021 vs. HLN (3.091). HLN (2.71B) and HLNCF (2.71B) have comparable annual earnings (EBITDA) . HLN (676M) and HLNCF (676M) have equal amount of cash in the bank . HLN (8.45B) and HLNCF (8.45B) have identical debt. HLN (11B) and HLNCF (11B) have equivalent revenues.
HLNHLNCFHLN / HLNCF
Capitalization43.4B43.7B99%
EBITDA2.71B2.71B100%
Gain YTD3.0915.02162%
P/E Ratio21.5422.2397%
Revenue11B11B100%
Total Cash676M676M100%
Total Debt8.45B8.45B100%
TECHNICAL ANALYSIS
Technical Analysis
HLNHLNCF
RSI
ODDS (%)
Bearish Trend 6 days ago
50%
N/A
Stochastic
ODDS (%)
Bearish Trend 6 days ago
61%
Bullish Trend 6 days ago
66%
Momentum
ODDS (%)
Bearish Trend 6 days ago
59%
Bearish Trend 6 days ago
70%
MACD
ODDS (%)
N/A
Bullish Trend 6 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
53%
Bullish Trend 6 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
49%
Bullish Trend 6 days ago
64%
Advances
ODDS (%)
Bullish Trend 13 days ago
56%
Bullish Trend 13 days ago
69%
Declines
ODDS (%)
Bearish Trend 15 days ago
52%
Bearish Trend 6 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
44%
Bearish Trend 6 days ago
76%
Aroon
ODDS (%)
Bullish Trend 6 days ago
47%
Bullish Trend 6 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signal:
Gain/Loss:
HLNCF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BTCO90.845.56
+6.52%
Invesco Galaxy Bitcoin ETF
EDGU28.380.12
+0.43%
3EDGE Dynamic US Equity ETF
LMBS50.010.02
+0.04%
First Trust Low Duration Oppos ETF
XTJA31.40N/A
-0.01%
Innovator US Equity Acclrtd Pls ETF Jan
IGBH24.55-0.09
-0.37%
iShares Interest Rate Hdg L/T Corp BdETF

HLNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
N/A
HLN - HLNCF
49%
Loosely correlated
-1.38%
SGIOF - HLNCF
21%
Poorly correlated
N/A
EAPIF - HLNCF
11%
Poorly correlated
N/A
ZTS - HLNCF
10%
Poorly correlated
-2.24%
TAK - HLNCF
10%
Poorly correlated
-1.04%
More